LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) today announced that it has raised an additional $125,000 through the sale of $125,000 in aggregate principal amount of its newly issued Senior Convertible Notes and warrants to selected institutional investors. The investors also have the option to invest an additional $4,000,000 at any time on or before February 1, 2010. The Company previously raised $875,000 through the sale of Senior Convertible Notes and warrants from the same institutional investors during the past three months.
